Lab-on-a-Chip Market Analysis

The market is segmented by application into proteomics, genomics, drug discovery, and diagnostics, out of which, the genomics segment is anticipated to occupy the largest share in the global lab-on-a-chip (LOC) market. This can be accounted to the growing utilization of LOC for integrating array of DNA probes, as it is able to sequence genomes at a thousand times faster rate. Additionally, on the basis of technology, the microfluidics segment is predicted to occupy the largest share during the forecast period owing to the high usage of this technology for manufacturing a wide range of consumer products. Apart from this, microfluidics reduces errors in cost management and provides good return on investment, which is also assessed to boost the market segment growth in the future.

Our in-depth analysis of the global market includes the following segments:

By Product Type

Software
Reagents & Consumables
Instruments

By Technology

Microarrays
Microfluidics

By Application

Proteomics
Genomics
Drug Discovery
Diagnostics

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of Lab-on-a-Chip is estimated at USD 7.13 billion.

Lab-on-a-Chip (LOC) Market size was over USD 6.54 billion in 2023 and is set to cross USD 26 billion by 2036, growing at more than 11.2% CAGR during the forecast period i.e., between 2024-2036. The market growth is driven by growing prevalence of chronic diseases, and rising demand for point of care testing globally.

Asia Pacific industry is predicted to hold largest revenue share by 2036, impelled by growing occurrence of cardiovascular and renal diseases, and rising developments in healthcare infrastructure in the region.

The major players in the market are Siemens AG, PerkinElmer, Inc., Becton, Dickinson, and Company, Agilent Technologies, Inc., Abaxis Inc., and others.

Lab-on-a-Chip Market Analysis